FTSJ1-mediated IL1RN mRNA instability promotes inflammation-driven hepatocellular carcinoma
High 2'-O-methyltransferase abundance predicts poor HCC prognosis. <i>FTSJ1</i> is a novel independent prognostic biomarker and oncogenic factor that promotes HCC progression by dysregulating the inflammatory response pathway, highlighting its translational potential in inflammation-driven HCC.
Authors
- Shuya Jiang
- Dongyang Ding
- Jian Yu
- Yunxi Zu
- Yan Liao
- Tengjiao Wang
Institutions
- Second Military Medical University (CN)
- Eastern Hepatobiliary Surgery Hospital (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.21037/jgo-2025-693
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00